Cargando…
Placental growth factor measurements in the assessment of women with suspected Preeclampsia: A stratified analysis of the PARROT trial
OBJECTIVE: Placental growth factor testing decreases time to recognition of preeclampsia and may reduce severe maternal adverse outcomes. This analysis aims to describe the clinical phenotype of women by PlGF concentration, and to determine the mechanism(s) underpinning the reduction in severe mater...
Autores principales: | Duhig, Kate E., Myers, Jenny E., Gale, Chris, Girling, Joanna C., Harding, Kate, Sharp, Andrew, simpson, Nigel A.B., Tuffnell, Derek, Seed, Paul T., Shennan, Andrew H., Chappell, Lucy C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909322/ https://www.ncbi.nlm.nih.gov/pubmed/33221705 http://dx.doi.org/10.1016/j.preghy.2020.10.005 |
Ejemplares similares
-
Diagnostic accuracy of repeat placental growth factor measurements in women with suspected preeclampsia: A case series study
por: Duhig, Kate E., et al.
Publicado: (2020) -
Placental growth fActor Repeat sampling for Reduction of adverse perinatal Outcomes in women with suspecTed pre-eclampsia: study protocol for a randomised controlled trial (PARROT-2)
por: Hurrell, Alice, et al.
Publicado: (2022) -
Placental growth factor testing for suspected pre‐eclampsia: a cost‐effectiveness analysis
por: Duhig, KE, et al.
Publicado: (2019) -
Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial
por: Duhig, Kate E, et al.
Publicado: (2019) -
Adverse maternal and perinatal outcomes in women with previous preeclampsia: a prospective study
por: Bramham, Kate, et al.
Publicado: (2011)